Deferoxamine Injection and Insulin Glargine (U-100) Vials
Determining the interaction of Deferoxamine Injection and Insulin Glargine (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: deferoxamine
Brand name: Desferal
Synonyms: Deferoxamine
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Deferoxamine Injection-Insulin Glargine (U-300) Pens
- Deferoxamine Injection-Insulin glargine and lixisenatide
- Deferoxamine Injection-Insulin glargine and lixisenatide Subcutaneous
- Deferoxamine Injection-Insulin glargine, recombinant Subcutaneous
- Deferoxamine Injection-Insulin glulisine
- Deferoxamine Injection-Insulin Glulisine (Cartridges and Pens)
- Insulin Glargine (U-100) Vials-Deferoxamine Mesylate
- Insulin Glargine (U-100) Vials-Defibrotide
- Insulin Glargine (U-100) Vials-Defibrotide Intravenous
- Insulin Glargine (U-100) Vials-Defibrotide Sodium
- Insulin Glargine (U-100) Vials-Definity
- Insulin Glargine (U-100) Vials-Defitelio